Works matching AU Buisseret, Laurence

Results: 15

Antigen Specificity and Clinical Significance of IgG and IgA Autoantibodies Produced in situ by Tumor-Infiltrating B Cells in Breast Cancer.

Published in:

Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.02660

By:

Garaud, Soizic;
Zayakin, Pawel;
Buisseret, Laurence;
Rulle, Undine;
Silina, Karina;
de Wind, Alexandre;
Van den Eyden, Gert;
Larsimont, Denis;
Willard-Gallo, Karen;
Linē, Aija

Publication type:

Article

The impact of cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i) on the incidence of alopecia in patients with metastatic breast cancer (BC).

Published in:

Acta Oncologica, 2020, v. 59, n. 6, p. 723, doi. 10.1080/0284186X.2020.1738547

By:

Eiger, Daniel;
Wagner, Marcio;
Pondé, Noam F.;
Nogueira, Melanie S.;
Buisseret, Laurence;
de Azambuja, Evandro

Publication type:

Article

Unraveling Triple-Negative Breast Cancer Tumor Microenvironment Heterogeneity: Towards an Optimized Treatment Approach.

Published in:

2020

By:

Bareche, Yacine;
Buisseret, Laurence;
Gruosso, Tina;
Girard, Edwina;
Venet, David;
Dupont, Floriane;
Desmedt, Christine;
Larsimont, Denis;
Park, Morag;
Rothé, Françoise;
Stagg, John;
Sotiriou, Christos

Publication type:

journal article

Immune Infiltration in Invasive Lobular Breast Cancer.

Published in:

2018

By:

Desmedt, Christine;
Salgado, Roberto;
Fornili, Marco;
Pruneri, Giancarlo;
Van den Eynden, Gert;
Zoppoli, Gabriele;
Rothé, Françoise;
Buisseret, Laurence;
Garaud, Soizic;
Willard-Gallo, Karen;
Brown, David;
Bareche, Yacine;
Rouas, Ghizlane;
Galant, Christine;
Bertucci, François;
Loi, Sherene;
Viale, Giuseppe;
Di Leo, Angelo;
Green, Andrew R.;
Ellis, Ian O.

Publication type:

journal article

Immunotherapy in breast cancer: an overview of current strategies and perspectives.

Published in:

NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00508-3

By:

Debien, Véronique;
De Caluwé, Alex;
Wang, Xiaoxiao;
Piccart-Gebhart, Martine;
Tuohy, Vincent K.;
Romano, Emanuela;
Buisseret, Laurence

Publication type:

Article

Post-Neoadjuvant Treatment Strategies for Patients with Early Breast Cancer.

Published in:

Cancers, 2022, v. 14, n. 21, p. 5467, doi. 10.3390/cancers14215467

By:

Agostinetto, Elisa;
Jacobs, Flavia;
Debien, Véronique;
De Caluwé, Alex;
Pop, Catalin-Florin;
Catteau, Xavier;
Aftimos, Philippe;
de Azambuja, Evandro;
Buisseret, Laurence

Publication type:

Article

Spatially distinct tumor immune microenvironments stratify triple-negative breast cancers.

Published in:

2019

By:

Gruosso, Tina;
Gigoux, Mathieu;
Kumar Manem, Venkata Satya;
Bertos, Nicholas;
Dongmei Zuo;
Perlitch, Irina;
Ismail Saleh, Sadiq Mehdi;
Hong Zhao;
Souleimanova, Margarita;
Johnson, Radia Marie;
Monette, Anne;
Muñoz Ramos, Valentina;
Hallett, Michael Trevor;
Stagg, John;
Lapointe, Réjean;
Omeroglu, Atilla;
Meterissian, Sarkis;
Buisseret, Laurence;
Van den Eynden, Gert;
Salgado, Roberto

Publication type:

journal article

Spatial transcriptomics reveals substantial heterogeneity in triple-negative breast cancer with potential clinical implications.

Published in:

Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-54145-w

By:

Wang, Xiaoxiao;
Venet, David;
Lifrange, Frédéric;
Larsimont, Denis;
Rediti, Mattia;
Stenbeck, Linnea;
Dupont, Floriane;
Rouas, Ghizlane;
Garcia, Andrea Joaquin;
Craciun, Ligia;
Buisseret, Laurence;
Ignatiadis, Michail;
Carausu, Marcela;
Bhalla, Nayanika;
Masarapu, Yuvarani;
Villacampa, Eva Gracia;
Franzén, Lovisa;
Saarenpää, Sami;
Kvastad, Linda;
Thrane, Kim

Publication type:

Article

Predictive Biomarkers for Response to Immunotherapy in Triple Negative Breast Cancer: Promises and Challenges.

Published in:

Journal of Clinical Medicine, 2023, v. 12, n. 3, p. 953, doi. 10.3390/jcm12030953

By:

Wang, Xiaoxiao;
Collet, Laetitia;
Rediti, Mattia;
Debien, Véronique;
De Caluwé, Alex;
Venet, David;
Romano, Emanuela;
Rothé, Françoise;
Sotiriou, Christos;
Buisseret, Laurence

Publication type:

Article

Neo-CheckRay: radiation therapy and adenosine pathway blockade to increase benefit of immuno-chemotherapy in early stage luminal B breast cancer, a randomized phase II trial.

Published in:

2021

By:

De Caluwé, Alex;
Buisseret, Laurence;
Poortmans, Philip;
Van Gestel, Dirk;
Salgado, Roberto;
Sotiriou, Christos;
Larsimont, Denis;
Paesmans, Marianne;
Craciun, Ligia;
Stylianos, Drisis;
Vandekerckhove, Christophe;
Reyal, Fabien;
Isabelle, Veys;
Eiger, Daniel;
Piccart, Martine;
Romano, Emanuela;
Ignatiadis, Michail

Publication type:

journal article

PIK3CA copy-number gain and inhibitors of the PI3K/AKT/mTOR pathway in triple-negative breast cancer.

Published in:

Cold Spring Harbor Molecular Case Studies, 2023, v. 9, n. 2, p. 1, doi. 10.1101/mcs.a006255

By:

Amato, Ottavia;
Buisseret, Laurence;
Gebhart, Géraldine;
Plouznikoff, Nicolas;
Larsimont, Denis;
Awada, Ahmad;
Piccart, Martine;
Aftimos, Philippe

Publication type:

Article

Author Correction: Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial.

Published in:

2023

By:

Buisseret, Laurence;
Loirat, Delphine;
Aftimos, Philippe;
Maurer, Christian;
Punie, Kevin;
Debien, Véronique;
Kristanto, Paulus;
Eiger, Daniel;
Goncalves, Anthony;
Ghiringhelli, François;
Taylor, Donatienne;
Clatot, Florent;
Van den Mooter, Tom;
Ferrero, Jean-Marc;
Bonnefoi, Hervé;
Canon, Jean-Luc;
Duhoux, Francois P.;
Mansi, Laura;
Poncin, Renaud;
Barthélémy, Philippe

Publication type:

Correction Notice

Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial.

Published in:

Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-42744-y

By:

Buisseret, Laurence;
Loirat, Delphine;
Aftimos, Philippe;
Maurer, Christian;
Punie, Kevin;
Debien, Véronique;
Kristanto, Paulus;
Eiger, Daniel;
Goncalves, Anthony;
Ghiringhelli, François;
Taylor, Donatienne;
Clatot, Florent;
Van den Mooter, Tom;
Ferrero, Jean-Marc;
Bonnefoi, Hervé;
Canon, Jean-Luc;
Duhoux, Francois P.;
Mansi, Laura;
Poncin, Renaud;
Barthélémy, Philippe

Publication type:

Article

Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial.

Published in:

Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-42744-y

By:

Buisseret, Laurence;
Loirat, Delphine;
Aftimos, Philippe;
Maurer, Christian;
Punie, Kevin;
Debien, Véronique;
Kristanto, Paulus;
Eiger, Daniel;
Goncalves, Anthony;
Ghiringhelli, François;
Taylor, Donatienne;
Clatot, Florent;
Van den Mooter, Tom;
Ferrero, Jean-Marc;
Bonnefoi, Hervé;
Canon, Jean-Luc;
Duhoux, Francois P.;
Mansi, Laura;
Poncin, Renaud;
Barthélémy, Philippe

Publication type:

Article

Comprehensive evaluation of methods to assess overall and cell-specific immune infiltrates in breast cancer.

Published in:

2019

By:

Nederlof, Iris;
De Bortoli, Davide;
Bareche, Yacine;
Nguyen, Bastien;
de Maaker, Michiel;
Hooijer, Gerrit K. J.;
Buisseret, Laurence;
Kok, Marleen;
Smid, Marcel;
Van den Eynden, Gert G. G. M.;
Brinkman, Arie B.;
Hudecek, Jan;
Koster, Jan;
Sotiriou, Christos;
Larsimont, Denis;
Martens, John W. M.;
van de Vijver, Marc J.;
Horlings, Hugo M.;
Salgado, Roberto;
Biganzoli, Elia

Publication type:

journal article